Chugai Commits $220M Into Singapore Drug Lab Post author:Sam Post published:December 28, 2017 Post category:BioPharma The drugmaker intends to expand development of therapeutic antibodies at the lab. Source: BioSpace You Might Also Like <b>Dynamk Capital</b> Announces First Closing And Launch Of Life Sciences Venture Fund September 25, 2017 Achillion Reports Second Quarter 2017 Financial Results And Proof-Of-Concept With A First-In-Class, Oral Factor D Inhibitor August 8, 2017 FDA Rejects Johnson & Johnson's RA Drug Sirukumab, More Safety Data Needed September 24, 2017
<b>Dynamk Capital</b> Announces First Closing And Launch Of Life Sciences Venture Fund September 25, 2017
Achillion Reports Second Quarter 2017 Financial Results And Proof-Of-Concept With A First-In-Class, Oral Factor D Inhibitor August 8, 2017
